Page 5 - Read Online

www.cdrjournal.com
Special Issue
Pharmacogenetics of Cancer
Guest Editors:
Prof. Enrico Mini, MD,
PhD
Department of Health
Sciences, Medical
Oncology, University of
Florence, Italy.
Email: enrico.mini@unifi.it
Dr. Stefania Nobili,
PharmD, PhD
Department of Health
Sciences, University of
Florence, Italy.
Email: stefania.nobili@unifi.it
Special Issue Introduction
Pharmacogenetics and pharmacogenomics has expanded rapidly
over the past years and is the basis of personalized medicine. The
pharmacological treatment of cancer is an ideal field for the
application of pharmacogenetics into clinical practice. Testing of
patients for genetic markers of efficacy or toxicity of anticancer
therapy is increasingly being used as a result of clinical studies based
on genotype stratification, availability of approved clinical tests and of
an always more robust clinical pharmacogenetic information and
guidelines.
This special issue of Cancer Drug Resistance is designed to provide an
overview of the role of pharmacogenetics and pharmacogenomics in
cancer treatment, including methods of discovery and clinical drug
development, available information on drug labels and web resources,
guidelines, with particular regard to specific cancer drug classes.
Finally, the integration of somatic pharmacogenomic markers into
clinical practice with examples of main cancer types will be also
addressed.
Benefits
Rigorous mechanism in peer review: one manuscript must be
reviewed by at least two relevant experts. We will endeavour to
ensure high standards for the review process and subsequent
publication by a team of efficient and professional reviewers and
scientific editors.
No publication fee: there would be absolutely no charge for
publication.
Rapid publication: we will ensure that accepted papers will be
published in a short processing time (the average processing time:
50.7 days) with a high quality.
Open Access: As an author you will retain the copyright to your work.
By licensing your work under the Creative Commons Attribution
License, articles can be re-used and re-distributed without restriction,
as long as the original work is correctly cited.
Wide promotions: Published articles will be promoted at academic
conferences, through social networks for scientists and relevant
indexing services.
245 E Main Street ste122, Alhambra, CA 91801, USAĠ www.cdrjournal.com
Telğ+1 323 9987086ĠE-mailğeditorial@cdrjournal.com